SCHEMBL9301003

SCHEMBL9301003

Cc1cnn2cc[nH]c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14269847 0.68 CRBN (0.38)
SCHEMBL13153943 0.64 KDM4E (0.31)
SCHEMBL21428039 0.62
SCHEMBL9299472 0.58 LPO (0.35)
SCHEMBL21236685 0.56 EPHB3 (0.46)
SCHEMBL84746 0.56 NPC1 (0.47)
SCHEMBL18357945 0.55 KDM4E (0.36)
SCHEMBL10308911 0.55 SCN5A (0.48)
SCHEMBL21236688 0.55
SCHEMBL21818710 0.54 SMPD3 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019189945-A1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-10-03 WO disclosed
US-5302712-A Intermediates for cephem compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-12 US disclosed
US-5215982-A Antibiotics FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-06-01 US disclosed
EP-0427248-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-05-15 EP disclosed